Department of Biochemistry and Molecular Biology, Dasman Diabetes Institute, Kuwait City, Kuwait.
Kuwait School Oral Health Program, Ministry of Health, Kuwait City, Kuwait.
Front Public Health. 2022 Jun 10;10:800373. doi: 10.3389/fpubh.2022.800373. eCollection 2022.
Childhood obesity presents a major risk for metabolic diseases in adulthood. Noninvasive methods are needed for predicting the course of obesity in children and its complications. Using blood for longitudinal analyses of biomarkers to predict disease in children is not a convenient method. Saliva presents a noninvasive platform to detect inflammatory changes in biomarkers as possible predictive measures of future pathological events.
The aim of this study was to evaluate the relationship between specific salivary biomarkers, obesity, and intermediate hyperglycemia in children. We also investigated the longitudinal association between the salivary biomarkers and change in Body Mass Index-for-age percentile scores (BMIz).
Data on 353 adolescents were collected from the individuals recruited for seven years in an ongoing Kuwait Healthy Life Study cohort. BMIz was measured at 10, 12, and 17 years of age. Interleukin (IL)-6, IL-8, IL-10, Leptin, C-Reactive Protein (CRP), Insulin, Vascular Endothelial Growth Factor (VEGF), and Monocyte Chemoattractant Protein-1 (MCP-1) were measured in saliva and serum. Additionally, fasting blood plasma glucose levels were recorded. Multilevel longitudinal regression modeling, mediation analyses, and logistic regression were used to determine the predictive value of salivary biomarkers in obesity and hyperglycemia.
Longitudinal analyses showed that with each one-unit increase of salivary CRP and insulin, there was a 3.5 kg/m and 3.2 kg/m increase in BMIz, respectively. Comparable to serum CRP and insulin, higher salivary CRP and insulin OR 4.94 [95%CI: 1.66,14., OR 2.64 [95%CI: 1.09, 6.38], respectively) were predictive of hyperglycemia and obesity (OR 4.53 [95%CI: 2.40,8.50], OR 3.29 [95%CI: 1.82,5.97], respectively). Insulin was a strong mediator in the relationship between obesity and hyperglycemia.
Our findings demonstrated that salivary CRP and insulin were associated with hyperglycemia, obesity, and possibly diabetes in adolescents. Salivary biomarkers are a noninvasive approach with significant value for disease risk assessment and prevention.
儿童肥胖症是成年期代谢性疾病的主要危险因素。需要非侵入性方法来预测儿童肥胖症的病程及其并发症。使用血液进行生物标志物的纵向分析来预测儿童疾病不是一种方便的方法。唾液提供了一个非侵入性的平台,可用于检测生物标志物中的炎症变化,作为未来病理事件的可能预测指标。
本研究旨在评估特定唾液生物标志物与肥胖症和儿童中间度高血糖之间的关系。我们还研究了唾液生物标志物与体重指数年龄百分位分数(BMIz)变化之间的纵向关联。
从正在进行的科威特健康生活研究队列中招募的个体中收集了 353 名青少年的数据,这些个体在七年的时间里接受了测量。在 10、12 和 17 岁时测量 BMIz。在唾液和血清中测量白细胞介素(IL)-6、IL-8、IL-10、瘦素、C 反应蛋白(CRP)、胰岛素、血管内皮生长因子(VEGF)和单核细胞趋化蛋白-1(MCP-1)。此外,还记录了空腹血浆葡萄糖水平。使用多水平纵向回归模型、中介分析和逻辑回归来确定唾液生物标志物在肥胖症和高血糖症中的预测价值。
纵向分析显示,唾液 CRP 和胰岛素每增加一个单位,BMIz 分别增加 3.5 公斤/平方米和 3.2 公斤/平方米。与血清 CRP 和胰岛素相似,较高的唾液 CRP 和胰岛素 OR 4.94[95%CI:1.66,14.,OR 2.64[95%CI:1.09,6.38])分别预测了高血糖症和肥胖症(OR 4.53[95%CI:2.40,8.50],OR 3.29[95%CI:1.82,5.97])。胰岛素是肥胖症和高血糖症之间关系的有力中介。
我们的研究结果表明,唾液 CRP 和胰岛素与青少年的高血糖症、肥胖症,甚至糖尿病有关。唾液生物标志物是一种非侵入性方法,对于疾病风险评估和预防具有重要意义。